UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Credit Rating
Announcement under Regulation 30(LODR) Credit Rating14-12-2023
14-12-2023
Unichem Labs offloads stake in Optimus Drugs for Rs 67 crore; shares rise
Unichem Laboratories noted that 4918 equity shares representing 0.02 percent holding in Optimus Drugs were sold05-12-2023
UNICHEM LABORATORIES LTD. - 506690 - Announcement Under Regulation 30 (LODR) - Update - December 4, 2023
Announcement under Regulation 30 (LODR) Update - December 4, 2023.04-12-2023
UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate under Regulation 39(3) of SEBI (Listing Obligations Disclosure Requirement), Regulations 2015.24-11-2023
UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Financial results for the second quarter and six months ended September 30, 2023, of the financial year 2023-24 were published in the newspapers on November 2, 2023.02-11-2023
UNICHEM LABORATORIES LTD. - 506690 - Board Meeting Outcome for Outcome Of Board Meeting Held On November 1, 2023
We would like to inform you that Board of Directors at its Meeting held today, i.e. Wednesday, November 1, 2023, approved the Unaudited Financial Results (Standalone & Consolidated) for the Second and Six months ended September 30, 2023 of the financial year 2023-24. Enclosed herewith please find the Unaudited Financial Results (Standalone & Consolidated) for the second quarter and six months ended September 30, 2023 of the financial year 2023-24, and the Auditors Reports thereon.01-11-2023
UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliance under Reg.(3) - intimation of loss of share certificate.19-10-2023
UNICHEM LABORATORIES LTD. - 506690 - Board Meeting Intimation for To Be Held On Wednesday, November 1, 2023, To Inter-Alia Consider And Approve The Unaudited Financial Results (Consolidated And Standalone) For The Second Quarter And Six Months Ended September 30, 2023.
UNICHEM LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2023 ,inter alia, to consider and approve Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, November 1, 2023, to inter-alia consider and approve the Unaudited Financial Results (Consolidated and Standalone) for the second quarter and six months ended September 30, 2023.18-10-2023
UNICHEM LABORATORIES LTD. - 506690 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulation 2018 for the quarter ended September 30, 2023.10-10-2023